AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Its deficiency also activated AKT/mTORC1 signaling pathway and cell cycle and inhibited the interaction of Foxo3a/β-catenin in the stem cell nucleus of chronic myeloid leukemia (PMID: 32943626).